Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.72 - $0.82 $5,830 - $6,640
8,098 Added 677.09%
9,294 $6,000
Q1 2024

Nov 05, 2024

SELL
$0.64 - $0.78 $5,182 - $6,316
-8,098 Reduced 87.13%
1,196 $0
Q1 2024

May 15, 2024

SELL
$0.64 - $0.78 $8,947 - $10,905
-13,981 Reduced 92.12%
1,196 $0
Q4 2023

Feb 14, 2024

BUY
$0.68 - $2.39 $4,508 - $15,845
6,630 Added 77.57%
15,177 $10,000
Q3 2023

Nov 14, 2023

BUY
$2.15 - $3.64 $8,971 - $15,189
4,173 Added 95.4%
8,547 $18,000
Q2 2023

Aug 14, 2023

BUY
$3.17 - $5.82 $7,189 - $13,199
2,268 Added 107.69%
4,374 $14,000
Q1 2023

May 15, 2023

SELL
$3.94 - $7.05 $5,709 - $10,215
-1,449 Reduced 40.76%
2,106 $8,000
Q4 2022

Feb 14, 2023

BUY
$4.7 - $9.98 $14,917 - $31,676
3,174 Added 833.07%
3,555 $18,000
Q3 2022

Nov 14, 2022

SELL
$4.13 - $8.79 $388 - $826
-94 Reduced 19.79%
381 $3,000
Q2 2022

Aug 15, 2022

SELL
$3.26 - $7.06 $5,336 - $11,557
-1,637 Reduced 77.51%
475 $2,000
Q1 2022

May 16, 2022

SELL
$6.75 - $13.52 $30,017 - $60,123
-4,447 Reduced 67.8%
2,112 $14,000
Q4 2021

Feb 14, 2022

BUY
$12.94 - $25.99 $47,347 - $95,097
3,659 Added 126.17%
6,559 $85,000
Q3 2021

Nov 15, 2021

BUY
$16.97 - $25.06 $7,263 - $10,725
428 Added 17.31%
2,900 $73,000
Q2 2021

Aug 16, 2021

BUY
$19.44 - $25.06 $48,055 - $61,948
2,472 New
2,472 $48,000

Others Institutions Holding ALVR

About Allovir, Inc.


  • Ticker ALVR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,063,400
  • Market Cap $40.9M
  • Description
  • Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...
More about ALVR
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.